No Data
No Data
Here's the Major Earnings Before the Open Tomorrow
Examining the Future: Kiniksa Pharmaceuticals's Earnings Outlook
Earnings Preview: KNSA to Report Financial Results Pre-market on April 29
Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $370,475, According to a Recent SEC Filing
Wedbush Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Maintains Target Price $34